Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2025
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinomaYichuan Yuan, Yi Niu, Zhenkun Huang, et al.Journal of Clinical and Translational Hepatology|August 14, 2023
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular CarcinomaKeren Li, Yi Niu, Kai Li, et al.ACS Nano|March 7, 2024
Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense SystemsNian Liu, Qian Lin, Zhenkun Huang, et al.International Journal of Surgery (London, England)|April 7, 2023
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching studyYichuan Yuan, Wei He, Zhiwen Yang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2025
Acid-activated mitochondria-targeting nanoprodrug for reactive oxygen species (ROS)-tolerant cancer therapy via antioxidant defense inhibitionZihao Teng, Chen Liu, Xiangfu Du, et al.International Journal of Molecular Sciences|July 13, 2024
KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR AxisYongjin Wang, Dinglan Zuo, Zhenkun Huang, et al.Cancer Medicine|May 8, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world studyLiang Qiao, Wei He, Guoying Wang, et al.Clinical and Translational Medicine|December 14, 2023
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1Zhiyu Qiu, Chenwei Wang, Pinzhu Huang, et al.Oncogene|May 2, 2022
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signalingKai Li, Yi Niu, Yichuan Yuan, et al.Clinical and Molecular Hepatology|January 20, 2026
COLEC12high TAMs Orchestrate Lenvatinib Resistance and Cancer Stemness in HCC via Paracrine NRG1-HER2/HER3 SignalingJianxing Zhang, Liang Qiao, Zongfeng Wu, et al.Pageof 4